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Abstract
Transport metabolons have been discussed between carbonic anhydrase II (CAII) and several membrane transporters. We
have now studied different CA isoforms, expressed in Xenopus oocytes alone and together with the electrogenic sodium
bicarbonate cotransporter 1 (NBCe1), to determine their catalytic activity and their ability to enhance NBCe1 transport
activity. pH measurements in intact oocytes indicated similar activity of CAI, CAII and CAIII, while in vitro CAIII had no
measurable activity and CAI only 30% of the activity of CAII. All three CA isoforms increased transport activity of NBCe1, as
measured by the transport current and the rate of intracellular sodium rise in oocytes. Two CAII mutants, altered in their
intramolecular proton pathway, CAII-H64A and CAII-Y7F, showed significant catalytic activity and also enhanced NBCe1
transport activity. The effect of CAI, CAII, and CAII mutants on NBCe1 activity could be reversed by blocking CA activity with
ethoxyzolamide (EZA, 10 mM), while the effect of the less EZA-sensitive CAIII was not reversed. Our results indicate that
different CA isoforms and mutants, even if they show little enzymatic activity in vitro, may display significant catalytic
activity in intact cells, and that the ability of CA to enhance NBCe1 transport appears to depend primarily on its catalytic
activity.
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+ homeostasis is important for all cell types,
because protons are involved in many processes of metabolism and
cellular function. The regulation of intra- and extracellular proton
concentration is due to proton buffer capacity, which includes the
CO2/HCO3
2-dependent and intrinsic buffer capacity, and the
active transport of acid-/base-equivalents across cell membranes.
Cells possess a number of ion transporters, which are involved in
the active transport of H
+ or HCO3
2, like sodium hydrogen
exchangers (NHE) [1] or the solute carrier family 4 of bicarbonate
transporters (SLC4) [2,3]. For several families of acid-/base-
coupled transporters an interaction of the transporter with
carbonic anhydrase II (CAII) has been shown, resulting in an
enhanced transport activity of the acid-/base-transporters [4–10].
CAII regulates the concentration of the substrate of the sodium
bicarbonate cotransporter 1 (NBCe1) by catalyzing the hydration
of CO2 and the dehydration of HCO3
2. A functional transport
metabolon between the two proteins has been suggested by several
groups [7,11]. We have previously shown an increase in transport
activity of NBCe1 by CAII in Xenopus oocytes as determined by an
increased membrane current, rate of rise of intracellular sodium
concentration and membrane conductance [12]. In contrast, other
groups could not find evidence for an interaction of CAII and
NBCe1 by determining the effect on membrane conductance of
NBCe1-expressing oocytes after an injection of CAII-protein [13]
or determining change of membrane current of NBCe1+CAII-
coexpressing oocytes [14].
We have now investigated the interaction of NBCe1 and CA by
the use of two additional intracellular isoforms of CA, CAI and
CAIII, and several CAII mutants with altered proton transfer. The
isoforms CAI and CAIII are known to exhibit different catalytic
activities than CAII - CAIII about 0.3% of CAII activity [15–17]
and CAI about 15% [18,19]. Replacement of the histidine at
position 64, which plays a central role for the proton shuttle in the
catalytically highly active CAII, with alanine (CAII-H64A),
resulted in a more than 10-fold decrease of the turnover number
in the absence of buffers in vitro [20,21]. Different amino acids
(Tyr7, Asn62, His64, Asn67, Thr199 and Thr200), located in the
active site of CAII, are involved in the stabilization of a network of
water molecules [22,23]. Mutation of CAII tyrosine at position 7
into a phenylalanine (CAII-Y7F) has been shown to lead to a
seven-fold increase of the proton transfer rate in direction of
dehydration [24], due to a less branched water wire [25]. An
increase in catalytic activity of this mutant could, however, not be
detected [25,26].
We have employed these CAII mutants, in addition to the two
intracellular isoforms CAI and CAIII, to explore the role of
catalytic activity and intramolecular proton shuttling of CA for
NBCe1 transport activity. Our results indicate that the interaction
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e27167of different CA-isoforms with NBCe1 solely depends on the
catalytic activity and appears to be independent of the intramo-
lecular proton shuttle in CA. Furthermore, the catalytic activity of
CAI, CAIII and the mutant CAII-H64A is increased or restored in
intact oocytes.
Materials and Methods
Constructs, oocytes, and injection of cRNA and carbonic
anhydrase
The CAI-cDNA (CAI-WT) was purchased from OriGene
Technologies (Rockville, USA). CAII-cDNA (CAII-WT) was
kindly provided by Dr. Reinhart Reithmeier [27]. The cDNA of
the catalytically inactive mutant CAII-V143Y was a gift from Dr.
Carol Fierke (Ann Arbor, USA) [28,29]. The cDNA of CAI, CAII,
CAII-V143Y, CAII-H64A [21,30], CAII-Y7F [24,25] and CAIII
was subcloned into the oocyte expression vector pGemHeJuel,
which contains the 59 and the 39 untranscribed regions of the
Xenopus b-globin. The human NBCe1 cDNA (hkNBCe1) was
cloned in the oocyte expression vector pGH19. Plasmid DNA was
linearized with NotI and transcribed in vitro with T7 RNA-
Polymerase in the presence of the cap analogon m7G(59)ppp(59)G
(mMessage mMachine, Ambion Inc., USA) to produce a capped
RNA transcript. The cRNA was purified with the RNeasy
MinElute Cleanup Kit (Qiagen GmbH, Hilden, Germany) and
stored at 280uC in DEPC-H2O. Xenopus laevis females were
purchased from Xenopus Express (Vernassal, France). Frogs were
anesthetized with 1 g/l of 3-aminobenzoic acid ethylester (MS-
222; Sigma-Aldrich, Taufkirchen, Germany), added to their bath,
rendered hypothermic and segments of ovarian lobules were
surgically removed. The procedure was approved by the Land-
esuntersuchungsamt Rheinland-Pfalz (Koblenz, Germany; 23 177-
07/A07-2-003 16).
Oocytes were isolated and singularized by collagenase treatment
(Collagenase A, Roche, Mannheim, Germany) in Ca
2+-free oocyte
saline at 28uC for 2 h. The singularized oocytes were left overnight
in an incubator at 18uCi nC a
2+-containing oocyte saline (pH 7.8)
to recover. The oocyte saline had the following composition (in
mM): NaCl, 82.5; KCl, 2.5; CaCl2, 1; MgCl2,1 ;N a 2HPO4,1 ;
HEPES, 5, titrated with NaOH to pH 7.4. Oocytes of the stages V
and VI were selected and injected with 13.8 ng of NBCe1-cRNA
using glass micropipettes and a microinjection device (Nanoliter
2000, World Precision Instruments, Berlin, Germany). CAI and
CAII were either injected as protein or coexpressed with the
NBCe1. For injection of protein, different amounts of CAI (0–
200 ng), isolated from human erythrocytes (Sigma-Aldrich), or
50 ng of CAII, isolated from bovine erythrocytes (Sigma-Aldrich),
dissolved in 27.6 nl DEPC-H2O, were injected 12–24 h before
oocytes were used for electrophysiological measurements. For
coexpression of CAI, CAII, CAIII or CAII-mutants, respectively,
11.5 ng CA-cRNA was injected either alone or together with the
NBCe1-cRNA.
Intracellular pH and Na
+ measurements
For measurement of intracellular pH (pHi) and membrane




microelectrodes were used; the manufacture and application have
been described in detail previously [31,32]. Briefly, for double-
barreled microelectrodes, two borosilicate glass capillaries of 1.0
and 1.5 mm in diameter were twisted together and pulled to a
micropipette. The ion-selective barrel was silanized with a drop of
5% tri-N-butylchlorsilane in 99.9% pure carbon tetrachloride,
backfilled into the tip. The micropipette was baked for 4.5 min at
450uC on a hot plate. H
+-sensitive cocktail (Fluka 95291, Fluka,
Buchs, Switzerland) was backfilled into the tip of the silanized ion-
selective barrel and filled up with 0.1 M Na-citrate, pH 6.0. The
reference barrel was filled with 3 M KCl. Calibration of the pH-
sensitive microelectrodes was carried out in oocyte salines by
changing the pH by 0.6 units. Electrodes were accepted for use in
the experiments, when their response exceeded 50 mV per unit
change in pH. For Na
+-sensitive microelectrodes, a 1.5 mm
borosilicate glass capillary was silanized as described above and
backfilled with Na
+- sensitive cocktail, made of 10 wt% sodium
ionophore VI (Fluka 71739), 89.5 wt% 2-nitrophenyl octyl ether
and 0.5 wt% sodium tetraphenylborate. The pipette was filled up
with a solution containing 100 mM NaCl and 10 mM MOPS
buffer, pH 7.0. Calibration was carried out in oocyte saline with
Na
+ concentrations of 5, 10, 15 and 84.5 mM. Na
+-selective
electrodes responded for a tenfold change in the Na
+ concentra-
tion (85 to 8.5 mM) with 58 mV, when Na
+ was replaced by
NMDG or Li
+, and with 54 mV, when Na
+ was replaced by K
+.
As described previously [33], optimal changes in ion concentration
were detected when the electrode was located near the inner
surface of the plasma membrane. All experiments were carried out
at room temperature. Oocyte saline titrated with N-methyl-D-
glucamine to pH 7.4 or 7.0 was used. The 24 mM bicarbonate-
buffered saline (pH 7.4) contained (in mM): NaCl, 58.5; KCl, 2.5;
CaCl2, 1; MgCl2,1 ;N a 2HPO4, 1; NaHCO3, 24, aerated with 5%
CO2 and HEPES, 5, to stabilize the pH. In 10 mM (pH 7.0) and
77 mM (pH 7.9) bicarbonate-buffered saline, NaCl was replaced
by an equimolar amount of NaHCO3.
The measurements of pHi were stored digitally using home-
made PC software based on the program LabView (National
Instruments Germany GmbH, Mu ¨nchen, Germany) and were
routinely converted into intracellular H
+ concentration [H
+]i.
Thus, changes in the [H
+]i are given, which take into account the
different pH baseline (see also: [34]). The amplitude and the rate
of change of the measured [H
+]i were analyzed.
Voltage clamp recording
A borosilicate glass capillary, 1.5 mm in diameter, was pulled to
a micropipette and backfilled with 3 M KCl. The resistance of the
electrodes measured in oocyte saline was around 1 MV. For
voltage-clamp, both electrodes were connected to the head-stages
of an Axoclamp 2B amplifier (Axon Instruments, USA). The
experimental bath was grounded with a chlorided silver wire
coated by agar dissolved in oocyte saline. Oocytes were clamped to
a holding potential of 240 mV.
Fluorescent staining of CA in oocytes
Oocytes, either injected with cRNA for CAI, II and III as well
as the mutants CAII-V143Y, -Y7F and -H64A, and native control
oocytes, were fixed in 4% paraformaldehyde in phosphate-
buffered saline (PBS). Oocytes were treated with 100% methanol
and permeabilized with 0.1% Triton X-100. Unspecific binding
sites were blocked with 3% bovine serum albumin (BSA; Sigma-
Aldrich) and 1% normal goat serum or 1% donkey serum,
depending on the secondary antibody. The cells were incubated in
1% BSA with 0.01% Triton X-100 containing the primary
antibodies against CAI (goat anti-human CAI, Lifespan Biosci-
ences), CAII (rabbit anti-CAII, Chemicon) and CAIII (goat anti-
human CAIII, Santa Cruz Biotechnology, Inc.) overnight at 4uC.
Oocytes were then incubated with the secondary antibody (Alexa
Fluor 488 goat anti-rabbit IgG or donkey anti-goat IgG,
Invitrogen, Darmstadt, Germany). The stained oocytes were
analyzed with a laser scanning microscope (LSM 510, Carl Zeiss
GmbH, Oberkochen, Germany), using whole oocytes, through
which cross sectional optical planes were laid.
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PLoS ONE | www.plosone.org 2 November 2011 | Volume 6 | Issue 11 | e27167Adobe Photoshop CS3 (Adobe Systems Inc., USA) was used to
process the images; all images of oocytes expressing the same CA-
isoform and corresponding controls (native oocytes) were treated
identically.
Quantification of CA expression by Western blot analysis
20 oocytes, expressing CAII, -H64A, -Y7F or -V143Y alone or
coexpressing NBCe1+CAII, as well as native oocytes (control), were
lysed in 200 ml 2% SDS (MP Biomedicals, Illkirch, France) with
protease inhibitors (Complete Mini EDTA-free, Roche Diagnostics
GmbH,Mannheim,Germany)bysonication.Afterdetermination of
total protein concentration (BCA
TM Protein Assay Kits; Thermo
Scientific, Rockford, USA), 12 or 15 mg total protein of oocytes were
loaded on a 4–12% NuPage
R Novex
R Bis-Tris Mini Gel (Invitrogen,
Carlsbad, USA) under reducing conditions. As protein standard,
5 mlN o v e x
R Sharp Pre-stained Protein Standard (Invitrogen) was




Cell (Invitrogen). Proteins were transferred on a nitrocellulose
membrane (0.45 mM; Invitrogen) by Western blotting. The
membrane was blocked for 1 hour in 50 mM Tris-HCl, pH 7.5,
150 mM NaCl, 0.2% Tween 20 and 5% skimmed dry milk
(TBST+L)beforeitwasincubated with the primaryantibodyagainst
CAII (1:500; rabbit anti-CAII, Chemicon) overnight at 4uC. After
washing inTBST, the incubation of the secondaryantibody (1:4000;
Goat anti-rabbit IgG-HRP, Santa Cruz) in TBST+Lf o r1h o u ra t
room temperature was performed. LumiLight Western Blotting
Substrate (Roche) was added and the CAII detected by Lumi-
Imager (VersaDoc Imaging System Model 3000; Biorad). As loading
control,b-tubulinwaslabeledwithanti-b-tubulinmousemonoclonal
antibody (1:2000; Sigma Aldrich). The PC-program Quantity One
(Biorad) was used for quantification analysis. After normalization of
the loading control, corrected values of CAII-stainings were
normalized to oocytes expressing wild-type CAII. Corel Draw X3
(Corel Corp.) was used to produce the final figures.
Determination of CA activity by mass spectrometry
Activity of CAI, II and III, as well as the mutant CAII-V143Y,
was determined by monitoring the
18O depletion of doubly labeled
13C
18O2 through several hydration and dehydration steps of CO2
and HCO3
2 at 25uC [35,36]. The reaction sequence of




18O (m/z=49) over the intermediate product
13C
18O




z=45) was monitored continuously with a quadrupole mass
spectrometer (MSD 5970; Hewlett Packard, Waldbronn, Germany).
The relative
18O enrichment was calculated from the measured 45,
47, and 49 abundance as a function of time according to: log
enrichment=log [496100/(49+47+45)]. For the calculation of the
CA activity of the sample, the rate of
18O degradation was obtained
from the linear slope of the log enrichment over the time, using the
spreadsheet analyzing software Origin 7.0 (OriginLab Corp.,
Northampten, MA). The rate was compared with the corresponding
rate of the non-catalyzed reaction before application of oocytes or
CA-protein into the cuvette. Enzyme activity in units (U) was
calculated from these two values as defined by Badger & Price [37].
From this definition, one unit corresponds to 100% stimulation of
the non-catalyzed
18O depletion of doubly labeled
13C
18O2.F o rt h e
experiments, the cuvette was filled with 8 ml of oocyte saline with a
pH of 7.35 according to the mean pHi of oocytes (data not shown),
8 ml of doubly labeled substrate was added. Experiments were
carried out at 25uC. To determine the catalytic activity, for each
sample, 20 intact, CA-expressing oocytes were pipetted into the
cuvette. Inside the cuvette the oocytes were rapidly lysed by stirring,
allowing measurement of CA activity. For calibration of CA activity,
0.25, 0.5, 1 and 2 mg of CAI- and CAII-protein were directly added
to the cuvette and compared to the activity of oocytes.
Calculation and statistics
Statistical values are presented as means 6 one standard error
of the mean (S.E.M.). For calculation of significance in differences,
ANOVA followed by Fishers LSD test was used (OriginPro 8;
OriginLab Corp.). In the figures shown, a significance level of
p#0.05 is marked with *, p#0.01 with ** and p#0.001 with ***.
Results
Expression of CA-isoforms and mutants of CAII
CA-expression was demonstrated by confocal images, taken
from CAI, II and III-expressing oocytes, as well as CAII-Y7F, -
H64A and -V143Y-expressing, and native oocytes, stained with
antibodies against CAI, CAII and CAIII, respectively. All CA
isoforms and mutants could be detected in the oocyte. In optical
slices the signal was restricted to the plasma membrane (Fig. 1).
Since using optical slices of whole oocytes results in limitations of
antibody diffusion and detection of fluorescence inside the oocytes,
the stainings are controls of expression of CA-isoforms in the
oocytes without determination of the exact cellular location.
Catalytic activity of CAI, II and III
We expressed CAI, CAII and CAIII, as well as the mutant
CAII-V143Y, in oocytes, to check for differences in catalytic
activity between the different CA-isoforms. Catalytic activity was
measured by pH-sensitive microelectrodes during application of
5% CO2/24 mM HCO3
2-buffered solution before and after
addition of the CA-inhibitor ethoxyzolamide (6-ethoxy-2-ben-
zothiazolesulfonamide; EZA; 10 mM; Fig. 2 A). The rate of rise of
proton concentration was enhanced 4.5- to 6.6-fold by CAI, II and
III, with only slight changes between the different isoforms (Fig. 2
B). Expression of the different CA-isoforms had no effect on the
intrinsic buffer capacity of the oocytes (native: 16.161.4 mM;
CAI: 13.661.8 mM; CAII: 14.061.2 mM; CAIII: 15.461.8 mM;
p=0.68). Catalytic activity of all three isoforms was inhibited by
EZA, but while CAI and CAII were blocked completely, CAIII
showed only partial inhibition (Fig. 2 B). Expression of CA
isoforms led to no significant difference in the absolute change of
the proton concentration during application of CO2/HCO3
2
(native: 9766 nM; CAI: 133625 nM; CAII: 10767 nM; CAIII:
107615 nM; and after addition of EZA: 80610 nM, 90631 nM,
76612 nM and 7269 nM, respectively; p=0.26). The catalyti-
cally inactive mutant CAII-V143Y did not show an increase of
rate of rise of proton concentration during application of CO2/
HCO3
2-buffered solution as compared to native oocytes, and
there was no reduction of the rate of rise of proton concentration
in the presence of EZA with this mutant (Fig. 2 B).
Another, independent, method for the determination of CA
activity is the CA-catalyzed degradation of
18O-labeled HCO3
2,
measured by mass spectrometry. Fig. 2 C shows
18O-depletion
after addition of 20 oocytes expressing either CA alone or
coexpressing CA with NBCe1. Catalytic activity of CAII-
(p#0.001) and CAI-expressing oocytes (p#0.05 or p#0.01), either
with or without coexpression of NBCe1, was increased as
compared to native or NBCe1-expressing control cells. CAIII-
expressing oocytes showed no measurable catalytic activity in mass
spectrometry, neither if expressed alone nor when coexpressed
with NBCe1. CAII-V143Y-expressing oocytes also showed no
measurable catalytic activity (see also: [12]). After subtraction of
background activity of the control oocytes (native: 4 U/ml and
NBCe1-expressing: 5 U/ml; per 20 oocytes, n=3), CAII-express-
CA Function on NBCe1 Activity
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with NBCe1 did not significantly alter this value (Fig. 2 D), while
CAI-expressing oocytes showed only about 30% of the activity of
CAII-expressing oocytes (p#0.001).
By means of mass spectrometric analysis, the amount of CAI-
and CAII-protein expressed in the oocytes was determined. For
this, catalytic activity of different concentrations of CAI- or CAII-
protein, directly added to the cuvette, was measured to create a
calibration curve (Fig. 2 E). This curve was used to determine the
concentration of active CAI and CAII expressed in oocytes after
injection of 11.5 ng cRNA for CAI and CAII, respectively (Fig. 2
F). The calculations revealed no difference in the amount of
expressed protein between CAI and CAII. Furthermore, coex-
pression with NBCe1 did not significantly affect the amount of
expressed CAI or CAII. Due to the low catalytic activity of CAIII
in mass spectrometry, the protein amount of this isoform could not
be calculated. However, in Western blot analysis, a concentration
of 65614 ng/oocyte was recently reported [26].
Effect of CAI and III expression on NBCe1-transport
activity
Transport activity of NBCe1, expressed in Xenopus oocytes, was
determined by measuring the membrane current and the
intracellular sodium concentration of oocytes, voltage-clamped
to a holding potential of 240 mV. NBCe1 was activated by
changing from a HEPES- to a 5% CO2/24 mM HCO3
2-buffered
solution (pH 7.4). This induced an outwardly directed membrane
current and a rise in intracellular sodium concentration in NBCe1-
expressing oocytes, indicating inwardly directed, electrogenic,
transport of Na
+ and HCO3
2 via NBCe1 (Fig. 3 A, D). There was
no significant change in current (2–9 nA; n=8–9) and intracel-
lular sodium concentration (0.02–0.07 mM/min; n=4) in oocytes
without NBCe1 when introducing CO2/HCO3
2 (Fig. 3 B, E).
CAI-coexpressing oocytes showed a CO2/HCO3
2-induced
membrane current of 928668 nA (n=11), CAIII-coexpressing
cells of 883681 nA (n=10), while oocytes just expressing NBCe1
showed a membrane current of only 656660 nA (n=12; Fig. 3
C). In the presence of the CA-inhibitor EZA (10 mM), the
application of CO2/HCO3
2-buffered solution led to a reduced
change of membrane current in CAI-coexpressing oocytes. On the
other hand, with a change of membrane current of 827657 nA
(n=9), coexpression of NBCe1 with the catalytically inactive
mutant CAII-V143Y led to no significant augmentation of the
membrane current during application of CO2/HCO3
2-buffered
solution, compared to NBCe1-expressing control oocytes with
733650 nA (n=9). Furthermore, application of EZA did not
induce any significant change of CO2/HCO3
2-induced mem-
brane current, which was 814659 nA in CAII-V143Y-coexpres-
sing oocytes as compared to 785643 nA in oocytes expressing
NBCe1 alone (see also: [12]).
The rate of rise of intracellular sodium concentration was also
increased during application of CO2/HCO3
2-buffered solution in
Figure 1. Fluorescent staining of CA isoforms and mutants. Optical slices of oocytes, labeled via primary antibodies and Alexa Fluor 488-
linked secondary antibodies against CAI (A), CAII (B), CAIII (C), CAII-Y7F (D), -H64A (E) and -V143Y-expressing oocytes (F). As control, a staining of
native, uninjected oocytes or oocytes injected with H2O with primary antibodies against CAI (G), CAII (H) and CAIII (I) as well as corresponding
secondary antibodies, respectively, was performed.
doi:10.1371/journal.pone.0027167.g001
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PLoS ONE | www.plosone.org 4 November 2011 | Volume 6 | Issue 11 | e27167CAI- (3.3-fold) and CAIII-coexpressing oocytes (2.3-fold) as
compared to NBCe1-expressing oocytes without CA (Fig. 3 F).
The increase of the NBCe1-transport activity between the two
CA-isoforms was not significantly different in membrane current,
but was different in rate of rise of intracellular sodium
concentration (p#0.05). Like the increase of membrane current,
the increase of the rate of rise of the intracellular Na
+-
concentration was reduced by EZA in the case of CAI. Oocytes
coexpressing NBCe1 showed no significantly lower rate of rise
of the sodium concentration or reduced membrane current
associated with the less EZA-sensitive CAIII in the presence of
the CA-inhibitor.
Figure 2. Activity of CAI, II and III. Original recordings of changes of intracellular proton concentration (DH
+; A) and statistical analysis of the rates
of rise of proton concentration (DH
+/t; B) after application of 5% CO2/24 mM HCO3
2-buffered solution before or during application of EZA (10 mM).
The asterisks above the bars correspond to the control cells without CA (2CA) before (2EZA) or during application of EZA (+EZA). (C) Original
recordings of the log enrichment of 20 oocytes expressing CAI, CAII and CAIII, respectively, either alone or together with the NBCe1, or 20 CAII-V143Y,
native or just NBCe1-expressing oocytes as measured by mass spectrometry (MS). The arrows indicate the application of 20 intact oocytes, which
were rapidly lysed inside the cuvette by stirring. (D) Statistical analysis of CA activity (U/ml) after subtraction of either native (4 U/ml; 20 oocytes,
n=3) or NBC-expressing oocytes (5 U/ml; 20 oocytes, n=3), as obtained by mass spectrometry. Oocytes expressing the catalytically inactive mutant
CAII-V143Y were used as control. Calibration curve of different CAI- and CAII-protein concentrations (E) to determine the amount of CA-protein
expressed in oocytes (F). The asterisks above the bars for NBCe1-coexpressing oocytes (+NBCe1, 13.8 ng NBCe1-RNA) correspond to those without
NBCe1-coexpression (2NBCe1). A significance level of p#0.05 is marked with *, p#0.01 with ** and p#0.001 with ***.
doi:10.1371/journal.pone.0027167.g002
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protein on catalytic activity and NBCe1 transport activity
The effect of CAI on NBCe1, which could be suppressed by
EZA, was studied in more detail by injecting different concentra-
tions of CAI-protein (0–200 ng) directly into NBCe1-expressing
oocytes 12–24 hours before the measurements were carried out.
Both, catalytic activity and NBCe1 transport activity were
enhanced in these oocytes with increasing concentration of CAI-
protein (Fig. 4 A, D).
The rate of rise of proton concentration during application of
5% CO2/24 mM HCO3
2-buffered solution in oocytes, indicative
for CAI catalytic activity, is illustrated in Figure 4 B for oocytes
without NBCe1 before (filled squares) and during application of
EZA (open squares). Half-maximal activity was determined at a
concentration of 5–10 ng CAI, maximal activity was obtained at
about 50 ng of protein. Even after injection of 10 ng CAI-protein,
a significant EZA-sensitive rate of rise of proton concentration
could be detected, as revealed in a plot, where the EZA-sensitive
rate of H
+ rise was isolated by subtraction of the values in the
absence and presence of EZA (Fig. 4 C).
The effect of CAI on the transport activity of NBCe1 was deter-
mined by evaluating the membrane current of NBCe1-expressing
oocytes (Fig. 4 D), before (filled squares) and during application of
EZA (open squares, Figure 4 E). Subtraction of the two curves
resultedintheEZA-sensitivechangeinmembranecurrent,indicating
the NBCe1 transport activity as augmented by catalytic activity of
CAI (Fig. 4 F). Half-maximal effect on the NBCe1 activity was
obtained with an injection of about 15 ng CAI-protein.
Figure 3. Effect of CAI or CAIII on NBCe1 transport activity. Original recordings (A) and statistics of the changes in membrane current (DIm;C )
of NBCe1- and NBCe1+CAI- or NBCe1+CAIII-expressing oocytes during application of 5% CO2/24 mM HCO3
2-buffered solution in the absence and
presence of EZA (10 mM). Original recordings of DIm of CA-expressing control cells without coexpression of NBCe1 (B). By the use of Na
+-selective
microelectrodes the rates of rise of intracellular sodium concentration (DNa
+/t; D, F) were obtained. Original recordings of DNa
+/t of control cells
without coexpression of NBCe1 (E). The asterisks above the bars correspond to the control cells without CA expression (2CA) before (2EZA) or
during application of EZA (+EZA).
doi:10.1371/journal.pone.0027167.g003
CA Function on NBCe1 Activity
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NBCe1 transport activity
The enzymatic activity of the two CAII mutants, CAII-H64A
and -Y7F, was determined by pH-sensitive microelectrodes during
application of CO2/HCO3
2-buffered solution before and during
application of EZA (10 mM). The rate of rise of proton concen-
tration was 6–7-fold increased by CAII, CAII-Y7F and -H64A
(p#0.001; Fig. 5 A, B). In the presence of EZA, the activity of CAII
and both mutants was completely blocked. The absolute changes
of proton concentration did not differ between the three CA-
expressing cell types and native oocytes (native: 94617 nM; CAII:
12166 nM; CAII-Y7F: 10868 nM; CAII-H64A: 113611 nM;
and after addition of EZA: 80622 nM, 104611 nM, 7565n M
and 90611 nM, respectively; p=0.1).
Figure 4. Effect of CAI-protein injection (0–200 ng) on the catalytic activity and NBCe1 transport activity. Original recordings of the
changes of intracellular proton concentration of CAI-injected oocytes (A) and of membrane current of CAI-injected, NBCe1-expressing oocytes (D)
after application of 5% CO2/24 mM HCO3
2-buffered solution in the absence and presence of EZA (10 mM). Rates of rise of proton concentration (B)
and changes of membrane current (E) before (filled squares) or during (open squares) EZA application in CO2/HCO3
2-buffered solution. EZA-sensitive
rates of rise of proton concentration (C) and changes of membrane current were plotted (F). The asterisks correspond to the control cells without CA-
injection (0 ng CAI).
doi:10.1371/journal.pone.0027167.g004
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PLoS ONE | www.plosone.org 7 November 2011 | Volume 6 | Issue 11 | e27167A potential role of the CA’s intramolecular proton shuttle for
the CAII-mediated augmentation of NBCe1 transport activity was
studied using these CAII mutants. The transport activity of
NBCe1, which was coexpressed with either mutant CAII-H64A
and -Y7F, in Xenopus oocytes, was determined by measuring the
membrane current and intracellular sodium concentration of
oocytes voltage-clamped to a holding potential of 240 mV during
application of a 5% CO2/24 mM HCO3
2-buffered solution.
Coexpression of NBCe1 with CAII-Y7F and -H64A induced a
significant increase in membrane current, as compared to oocytes
expressing NBCe1 alone (p#0.01; Fig. 5 C, D). No significant
difference in the CA-induced augmentation of NBCe1 transport
Figure 5. Activity and effect of CAII mutants on NBCe1 transport activity. Changes of the intracellular proton concentration as recorded in
native, CAII-, CAII-H64A- and CAII-Y7F-expressing oocytes (A) to determine rates of rise of the proton concentration (B). Original recordings of the
changes in membrane current (C) and intracellular sodium concentration (E) in NBCe1 and CAII-, CAII-H64A- or CAII-Y7F- coexpressing oocytes after
application of 5% CO2/24 mM HCO3
2-buffered solution before or during application of EZA (10 mM). Statistical analysis of membrane current (D) and
rates of rise of intracellular sodium concentration (F) revealed an increase in NBCe1 transport activity after coexpression of either CAII or one of the
two mutants. The asterisks above the bars correspond to the control cells without CA (2CA) before (2EZA) or during EZA (+EZA) application.
doi:10.1371/journal.pone.0027167.g005
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EZA, which blocked the CA activity of both mutants and CAII,
also reversed the increase in NBCe1 transport current.
CAII and both CAII mutants also induced a significant increase
in the rate of NBCe1-mediated change in intracellular sodium
concentration during application of CO2/HCO3
2-buffered solu-
tion (Fig. 5. E, F). Again, there was no difference in the
augmentation of NBCe1 transport activity between CAII and
the two CAII mutants. Similar to the membrane current, there
was a complete blockade of the CA-mediated increase in the rate
of sodium rise by EZA in CAII and CAII-H64A-coexpressing cells
(p#0.01), whereas the blockade was not significant in CAII-Y7F-
coexpressing oocytes (p=0.065). There was no change in
membrane current (22 nA–14 nA; n=7–9) and intracellular
sodium concentration (0.0–0.2 mM/min; n=3–5) in control
oocytes without NBCe1.
Effect of injected CAII-protein on NBCe1 transport activity
at different bicarbonate concentrations and constant CO2
To exclude effects of a CO2-mediated acidification during the
initial phase of application of 5% CO2/24 mM HCO3
2-buffered
solution, we changed the bicarbonate concentration from
10 mM to 77 mM in the constant presence of 5% CO2.T h e
transport activity of NBCe1-expressing oocytes injected with
50 ng CAII-protein, both after changing from a HEPES-
buffered, bicarbonate-free saline (pH 7.0) to a 5% CO2/
10 mM HCO3
2-buffered saline, as well as after increasing the
HCO3
2 concentration from 10 mM (pH 7.0) to 77 mM HCO3
2
(pH 7.9) in a 5% CO2-equilibrated saline, was increased as
compared to NBCe1-expressing oocytes without injection of CA
(Fig. 6 A, B). The enhancement of NBCe1 transport activity after
increasing the HCO3
2 concentration from 10 mM to 77 mM
HCO3
2 in a 5% CO2-equilibrated saline could be reversed by
EZA (10 mM). There was no change in membrane current in
control oocytes without NBCe1 (n=4). Catalytic activity of
CAII-protein was confirmed by a 5-fold increase in the rate of
rise of proton concentration, induced by application of 5% CO2/
10 mM HCO3
2, in oocytes injected with 50 ng CAII-protein, as
compared to water-injected native oocytes (Fig. 6 C, D). These
results indicate that the enhancement of NBCe1 transport
activity by CA activity is independent of a change in CO2
concentration.
Figure 6. Effect of injected CAII-protein on NBCe1 transport activity at different bicarbonate concentrations and constant CO2.
Original recordings of membrane current (A) in NBCe1-expressing oocytes with or without injection of 50 ng CAII-protein after changing from a HEPES-
buffered, bicarbonate-free saline (pH 7.0) to a 5% CO2/10 mM HCO3
2-buffered saline (pH 7.0) as well as after increasing the HCO3
2 concentration from
10 mM (pH 7.0) to 77 mM HCO3
2 (pH 7.9) in a 5% CO2-equilibrated saline, before or during application of EZA (10 mM). Statistical analysis of membrane
current(B)revealedanincreaseinNBCe1transportactivityafterinjectionofCAII-proteininbothsalines.Originalrecordingsofthechangeofintracellular
proton concentration (C) and statistical analysis of rate of rise of proton concentration (D) of native oocytes and oocytes injected with CAII-protein. The
asterisks above the bars correspond to the control cells without CA (2CA) before (2EZA) or during EZA (+EZA) application.
doi:10.1371/journal.pone.0027167.g006
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A quantification of the expression of CAII and the different CAII
mutants by Western blot was performed to reveal a potential
influence of NBCe1 expression on the amount of expressed CA. The
Western blots showed a band corresponding to CAII at 35 kDa.
Native oocytes did not show any bands in the Western blot. Statistical
analysis indicated no significant difference between the CAII mutants
H64A, Y7F and V143Y in comparison to CAII-expressing oocytes
normalized to 100% density INT/mm
2, suggesting similar CA
expression of wild-type and CAII mutants (Fig. 7 A, B).
Figure 7 C shows a Western blot for the quantification of CAII
in NBCe1/CAII-coexpressing oocytes with a band corresponding
to CAII at about 30–35 kDa. In comparison to CAII-expressing
oocytes normalized to 100% density of intensity/mm
2, NBCe1+-
CAII-coexpressing cells showed no significant change in the
expression of CAII (n=7; Fig. 7 D). The loading control b-tubulin
was used as expression level standard in these calculations, as
described in the Methods section.
Discussion
Effect of CAI, CAII and CAIII on NBCe1 transport activity
We have recently shown that NBCe1 transport activity is
enhanced by coexpression of CAII or after injection of CAII-protein
into Xenopus oocytes [12], and that catalytic activity of CAII is
important for this interaction. In contrast, other groups could not
find such an interaction between NBCe1 and CAII by examining
the change of membrane conductance [13] or determining change
of membrane current [14]. We have now investigated the effect of
two other intracellular isoforms of CA, CAI and CAIII, on the
transport activity of NBCe1 after expression of the proteins in
Xenopus oocytes. By recording the membrane current and the
intracellular sodium concentration, both robust parameters of
NBCe1 transport activity, during application of CO2/HCO3
2-
buffered solution, we were able to show that NBCe1 transport
activity is enhanced by each of these isoforms to a similar extent
(Fig. 3). The effect of CAI could be reversed, by blocking the
catalytic activity with the CA-inhibitor EZA. CAIII exhibits less
sensitivity against sulfonamides due to a reduced accessibility of its
active site [38], and hence its effect on NBCe1 activity was not
significantlyreduced byEZA.Inaddition,wewereabletoshowthat
the enhancement of NBCe1 by CAII occurs also by changing the
HCO3
2 concentration under constant CO2-equilibration. Our
results show that there is a functional interaction between NBCe1
and different intracellular CA-isoforms, which results in an
increased transport activity by NBCe1 allowing more efficient
acid-/base-regulation.
Figure 7. Quantification of CAII mutants. Western blot of the different CAII mutants (CAII-Y7F, CAII-H64A andCAII-V143Y) as well as wild-type CAII
(A; 12 mg total protein/lane), b-tubulin was used as loading control, and quantification of the expression of the CAII mutants in oocytes, as compared to
wild-typebydeterminationof the densityof intensity (B;Density INT/mm
2). Western blot ofCAII-expressing andNBCe1+CAII-coexpressingoocytes, with
b-tubulin used as loading control (C; 15 mg total protein/lane) and quantification of effect of NBCe1 coexpression on CAII expression rate (D).
doi:10.1371/journal.pone.0027167.g007
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It was reported that the catalytic activity of CAI is about 15%
[18,19] and that of CAIII about 0.3% of the activity of CAII [15–
17]. This difference in catalytic activity was attributed to the
difference in the amino acids lining the active site of the respective
enzymes. The catalytic site of CAII has, besides the three zinc
ligands, only one further histidine (His64), whereas the catalytic
site of CAI exhibits three additional histidines [39,18]. A further
major difference is a histidine-rich cluster of CAII, which reaches
from the middle of the active site to the surface of the protein and
acts presumably as a proton shuttle [40]. CAIII does not possess a
histidine on position 64, but instead a lysine (Lys64), which is less
effective as a proton shuttle [38,41,42]. Furthermore, in position
198, CAIII has a phenylalanine, which has a very bulky side chain
and seems to reduce CAIII activity even more [43]. Whereas the
physiological function of CAII is well understood, the functional
roles of CAI and CAIII are much less clear. CAIII is expressed in
high concentrations in the red skeletal muscle, while CAI is
expressed primarily in red cells, gastrointestinal epithelia or
vascular epithelium (for review see: [44]).
We also checked the catalytic activity of the three isoforms in
mass spectrometry under in vitro conditions. We were able to
confirm the results of the in vitro measurements of other groups
[15,19]. We found for CAI-expressing oocytes about 30% activity,
whereas CAIII-expressing oocytes, as well as oocytes expressing
the catalytic inactive mutant CAII-V143Y, did not show any
measurable catalytic activity. The expression of CAI and CAII in
oocytes was equal (about 50 ng/oocyte), and no effect on the
expression level of CAI or CAII was observed when coexpressed
with NBCe1. Protein expression of CAIII on the other hand could
not be determined by the use of mass spectrometry because of the
low catalytic activity in the in vitro measurement. However, we
have recently shown by Western blot analysis a CAIII concentra-
tion of 65614 ng/oocyte [26].
CA activity in intact oocytes
Both CAI and CAIII showed significant catalytic activity in
intact oocytes, as determined by the rate of acidification during
application of CO2/HCO3
2, confirming our previous studies on
CAI [45] and CAIII [26]. The intrinsic buffer capacity was not
altered by the expression of either CA-isoform. However, oocytes
expressing the catalytically inactive mutant CAII-V143Y did not
show any activity, as expected, similar to that of native oocytes.
It appears that the activity of CAI and CAIII has been restored
or activated by a yet unknown factor in the cytosol, while CAII
activity might be reduced. Scozzafava and Supuran [46] have
shown an increase of catalytic activity of CA by micromolar
concentrations of histamine or ‘new activators’, such as e.g.
carnosine and imidazole derivates, in human erythrocytes.
Histidine-containing dipeptides like carnosine, homocarnosine
and anserine have also been detected as intracellular mobile H
+-
buffers in cardiac and skeletal muscle [47–49]. Jonsson et al. [50]
have shown an increase of CAII activity by several buffers, e.g.
1,2-dimethylimidazole or 2,2-diethylmalonate. The activity of
CAIII was also shown to be increased by small mobile buffers,
especially imidazole, in membrane-inlet mass spectrometry and
stopped-flow spectrophotometry [30,51].
The restoration or increase of CA activity in intact oocytes
might explain that all three catalytically active isoforms enhanced
transport activity of NBCe1. It can be speculated that if catalytic
activity of CAs could be rescued by substances in the cytosol of
oocytes, catalytic activity might be suppressed due to the absence
of these yet unknown factors in in vitro measurements due to the
high dilution of the cytosol with HEPES-buffered solution, as e.g.
in mass spectrometry. Recently, the membrane conductance
associated with the glutamine transporter SNAT3 (SLC38A3) was
shown to be suppressed not only by CAII activity [52], but also by
CAI and CAIII [53].
Functional interaction of CA and NBCe1
In addition to the finding of this study that CAI and CAIII have
an enhancing effect on transport activity of NBCe1, we have also
investigated the effect of injection of different concentrations of
CAI on catalytic activity and NBCe1 transport activity. The effect
of CAI on NBCe1 transport activity increased with the
concentration of CAI and hence in parallel with the catalytic
activity of CA. Even an injection of 10 ng CAI led to a detectable
catalytic CA activity, and injection of 10 ng CAI resulted in a
significant increase of EZA-sensitive NBCe1 activity. Maximal CA
activity and enhancement of NBCe1 transport activity was
obtained after injection of 45–50 ng CAI. The values for CAI
activity fit well to previous measurements, which gave an EC50 of
11.061.6 ng CAI/oocyte and a near maximal rate of acidification
at ,50 ng CAI [45]. This means that oocytes expressing or
coexpressing CAI with about 50 ng per oocyte, as used in this
study, show near maximal catalytic activity as well as near
maximal effect on NBCe1 transport activity in oocytes, similar as
previously shown for CAII in oocytes [12].
We also investigated a potential role of the intramolecular
proton shuttle in CAII on NBCe1 transport activity by coexpres-
sion of the mutants CAII-H64A and -Y7F together with the
bicarbonate transporter. This intramolecular proton shuttle was
shown to be essential for the CAII-mediated increase in transport
activity of the monocarboxylate transporters (MCT) 1 and 4 [26].
When coexpressed with NBCe1, both mutants showed the same
effect on NBCe1 transport activity as described for the wild-type
CAII, as demonstrated by a similar increase of membrane current
and rate of rise of intracellular sodium concentration during
application of CO2/HCO3
2-buffered solution. It may be
speculated, that the proton transfer of CA can be rescued by
substances in the cytosol of the oocytes so that catalytic activity is
restored. The CAII-H64A mutant, which was shown to exhibit
less than 10% of wild type enzyme activity in in vitro measurements
[20,21], had indeed similar catalytic activity as CAII-WT and
CAII-Y7F, as determined from the rate of rise of intracellular
proton concentration, in intact oocytes. This increase in CAII-
H64A activity is not attributable to an altered expression level of
wild-type CAII and CAII mutants, as shown by a quantitative
Western blot analysis of CAII expression (Fig. 7). We were also
able to show by quantitative Western blot analysis that there is no
effect on the expression level of CAII when coexpressing NBCe1
with CA. In contrast to another report [14], we were able to show
that there is very little endogenous CAII present in our Xenopus
oocytes. Equal expression of NBCe1 was confirmed by a
comparison of NBCe1 transport activity of NBCe1 alone and
when coexpressed with CA in the presence of the CA-inhibitor
EZA (Fig. 5 D, F).
By the use of the three different intracellular CA-isoforms, we
were also able to gain insight into the type of interaction between
CA and NBCe1. For anion exchanger 1 (AE1), which is, like
NBCe1, a member of the SLC4-family of bicarbonate transport-
ers, a direct binding between an acidic motif in intracellular C-
term of AE1 (D
887ADD) and a basic binding motif in N-term of
CAII was suggested [27,54]. Furthermore, Pushkin et al. [11] have
shown a direct binding between an acidic motif in the intracellular
C-terminal of NBCe1 (L
958DDV and D
986NDD) and immobilized
CAII. Another report, however, could neither detect a binding of
CAII to the immobilized pure NBCe1- or AE1-Ct peptides, nor
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peptides in surface plasmon resonance spectroscopy [55]. Even
though CAI lacks the histidine cluster, which is suggested to bind
to the C-terminal of AE1-3 and NBCe1, and although CAIII
contains only parts of this cluster (Fig. 8), both CA-isoforms
showed a similar effect on NBCe1 transport activity as CAII does.
Furthermore, we have shown previously that mutation of this
histidine-rich cluster (H3P, H4Q, K9A, H10K, H15Q, H17S)
does not impair the CAII-induced augmentation of NBCe1-
transport activity [12], while the interaction between MCT1 and
CAII was abolished by this mutation [45]. Therefore, the CAII-
mediated augmentation of NBCe1 transport activity may not
require the basic binding motif within the N-terminal of the
enzyme.
Carbonic anhydrases but also NBCe1 are expressed in various
organs. A possible interaction of NBCe1 and CAII could for
example take place in the kidney or brain, where an expression of
both proteins has been shown (see for review: [2,19]). CAI is
expressed in the colon [56,57] and CAIII is highly expressed in the
human skeletal muscle [58], both could interact with NBCe1,
which is also present in these tissues [59,60].
In conclusion, we have shown for the first time that both
intracellular isoforms, CAI and CAIII, enhance NBCe1 transport
activity, similar to that of intracellular CAII, after heterologous
expression in Xenopus oocytes. This effect is likely to be attributable
to the catalytic activity of the different CA isoforms. CAIII showed
robust catalytic activity in intact cells, and was therefore, similar as
CAI and CAII, enhancing NBCe1 transport activity. Our results
indicate that the augmenting of NBCe1 activity does not require
the intramolecular proton shuttle of CAII, which is possibly
rescued in the intact oocyte, just as found for the enzymatic
activity of the in vitro less active isoforms CAI and III.
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